Gadolinium (Gd) based contrast agents (CAs)(Gd-CAs) represent one of the most advanced
developments in the application of Gd for magnetic resonance imaging (MRI). Current …

The ability to detect and monitor amyloid deposition in the brain using non-invasive imaging
techniques provides valuable insights into the early diagnosis and progression of …

Despite the wide use of magnetic resonance imaging (MRI) as a clinical diagnostic tool,
there are still no clinically approved MRI contrast agents that can be applied for cerebral …

Noninvasive imaging of amyloid-β (Aβ) species in vivo is important for the early diagnosis of
Alzheimer's disease (AD). In this paper, we report a near-infrared (NIR) fluorescence (FL) …

Alzheimer's disease (AD), an amyloid-related disease, seriously endangers the health of
elderly individuals. According to current research, its main pathogenic factor is the amyloid …

Alzheimer's disease (AD) is a neurodegenerative condition that poses multiple challenges
for disease diagnosis and treatment. Biomarker-based assays are one of the important tools …

Aβ oligomers have been widely accepted as significant biomarkers for Alzheimer's disease
(AD) detection, monitoring, and therapy since they are highly correlated with AD …

Alzheimer's disease is the most common cause of dementia and a leading cause of mortality
in the elderly population. Diagnosis of Alzheimer's disease has traditionally relied on …

Amyloid forms of many different proteins have been long identified as relevant biomarkers in
important pathologies with high societal impact, including Aβ in Alzheimer's disease, amylin …

Glutamate is an important excitatory neurotransmitter, and vesicular glutamate transporters
(VGLUTs) are critical in regulating the extent of glutamate release. Because initial increase …